Pharmacy Associations Oppose Rescheduling of Hydrocodone Combination Products

Published Online: Monday, June 16, 2014
Follow Pharmacy_Times:
In a joint pharmacy stakeholder comment letter to the Drug Enforcement Administration, the American Pharmacists Association, National Association of Chain Drug Stores, National Community Pharmacists Association, and other organizations argued that rescheduling hydrocodone combination products from Schedule III to Schedule II will harm legitimate pain patients while doing little to curb abuse.

Rescheduling would mean that patients would need to visit their physicians in order to refill prescriptions for the painkillers, potentially delaying treatment for those with legitimate pain, the letter notes. These patients may have to wait for an appointment or the ability to take time off work to visit a physician, and patients living in rural or medically underserved areas may have to wait even longer to receive treatment. In addition, most patients taking hydrocodone combination products use the medications appropriately, the letter notes.

Rescheduling the medications could also cause inefficiencies in the health care system, the letter adds.

“With approximately 50 million patients taking [hydrocodone combination products], meeting the new demands associated with rescheduling [hydrocodone combination products] may cripple an already overtaxed system,” the letter reads. “Moreover, pharmacies and distributors will have to comply with stricter storage and handling laws for Schedule II controlled substances, and such requirements may cause delays in maintaining an adequate supply of [hydrocodone combination products].”

Related Articles
Tighter hydrocodone regulations meant to reduce opioid abuse are hindering pain patients’ access to the products.
The National Association of Boards of Pharmacy in conjunction with various other stakeholder organizations has recently released a consensus document titled “Stakeholders’ Challenges and Red Flag Warning Signs Related to Prescribing and Dispensing Controlled Substances.”
Fed up with alleged unpaid overtime and missed rest periods, a Walmart pharmacist is fighting back against the retail giant with a class action suit.
Five pharmacy schools received kudos from the CEO of the American Pharmacists Association for earning the highest rates of participation in the Pharmacists Provide Care Campaign.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$